Plasma Sphingolipid Profiling Predicts Radiosensitivity in Hepatocellular Carcinoma
Introduction Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally, with over 800,000 new cases and approximately 750,000 deaths annually, posing a major public health challenge.1 Radiotherapy (RT) occupies a pivotal role in the …